Evidence map›Paper›PMID 41845051›Full record

ArticleCellular & molecular immunology2026

The type-I interferon priming signal balances antibacterial and antitumor trained immunity in alveolar macrophages.

Tao Wang, Jinjing Zhang, Ying Li, Yuxuan Miao, Yanling Wang, Lu Wang, Yuanyuan Liu, Chia-Wei Chang, Enguo Chen, Yushi Yao

Abstract read
In one paragraph

Article in Cellular & molecular immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tao Wang *Department of Respiratory Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. wangtao0101@zju.edu.cn.ORCID 0009-0002-9388-2307
Jinjing Zhang *Department of Clinical Laboratory, Women's Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Ying Li *Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Yuxuan Miao *Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Yanling WangInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Lu WangInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Yuanyuan LiuInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Chia-Wei ChangInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou, China.
Enguo ChenDepartment of Respiratory Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. 3195024@zju.edu.cn.
Yushi YaoInstitute of Immunology, Zhejiang University School of Medicine, Hangzhou, China. yaoyushi@zju.edu.cn.ORCID 0000-0003-1715-6805

Funding

China Postdoctoral Science Foundation 2024M752824China Postdoctoral Science Foundation GZC20241486National Natural Science Foundation of China (National Science Foundation of China) 31970861National Natural Science Foundation of China (National Science Foundation of China) 32100714National Natural Science Foundation of China (National Science Foundation of China) 32170893National Natural Science Foundation of China (National Science Foundation of China) 32400742National Natural Science Foundation of China (National Science Foundation of China) 32470947Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LR20H100001Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LRG25H100001
6 · The paper itself

Abstract

Tissue-resident macrophages may be trained to confer an enhanced response to heterologous restimulation and thus foster versatile trained immunity (TI) against both infections and tumors. However, the key priming signals that contribute to such functional versatility in trained macrophages are not fully understood. Here, we show that influenza A virus (IAV) infection in mice induces lasting transcriptional imprints of acute type-I interferon (IFN-I) signaling in lung-resident alveolar macrophages (AMs) that confer balanced antibacterial and antitumor TI responses. In both IAV-infected mice and an ex vivo cytokine-mediated training system, IFN-I signaling is critical for the development of antitumor TI functions, although it limits antibacterial TI functions in AMs. Moreover, human AMs carrying transcriptional imprints of IFN-I signaling are associated with immune activation in lung cancer tissues. Our findings highlight IFN-I as a key priming signal required for the development of versatile TI functions in AMs with balanced antibacterial and antitumor potential.

Indexed as

Interferon Type ILung NeoplasmsMacrophages, AlveolarOrthomyxoviridae InfectionsSignal TransductionTrained ImmunityAnimalsHumansInfluenza A virusMiceMice, Inbred C57BLInterferon Type Ialveolar macrophagesinfluenzainnate immune memoryTrained immunitytype-I interferon

Identifiers

PMID41845051
PMCPMC13128894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.